Joan Buch

Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain

Carmen Martı́nez, Cecilia Carpio, Inmaculada Heras et al. · Biology of Blood and Marrow Transplantation · 2020 · 26 citations · Full text

Medicine, Hematology, Oncology +17

Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors

Anna Bosch-Vizcaya, Arianne Pérez-García, Salut Brunet et al. · Biology of Blood and Marrow Transplantation · 2011 · 20 citations · Full text

Life Sciences, Hematology, Immunology +16

<scp>FMOD</scp> expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study

Marc Sorigué, Jordi Juncà, Christelle Ferrá et al. · Cytometry Part B Clinical Cytometry · 2020 · 15 citations · Full text

Medicine, Hematology, Pathology +14

Population-based incidence of lymphoid neoplasms: Twenty years of epidemiological data in the Girona province, Spain

Marta Solans, Anna Fàbrega, David Morea et al. · Cancer Epidemiology · 2018 · 12 citations · Full text

Veterinary Medicine, Immunology, Oncology +15